CYMABAY THERAPEUTICS INC's ticker is and the CUSIP is 23257D903. A total of 3 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $903 | -17.2% | 60,600 | -39.2% | 0.00% | 0.0% |
Q2 2023 | $1,091 | +5.8% | 99,700 | -15.7% | 0.00% | 0.0% |
Q1 2023 | $1,031 | +293.5% | 118,300 | +183.0% | 0.00% | – |
Q4 2022 | $262 | -99.5% | 41,800 | +154.9% | 0.00% | – |
Q3 2022 | $57,000 | -8.1% | 16,400 | -23.0% | 0.00% | – |
Q2 2022 | $62,000 | +158.3% | 21,300 | +166.2% | 0.00% | – |
Q1 2022 | $24,000 | -69.2% | 8,000 | -65.4% | 0.00% | – |
Q4 2021 | $78,000 | -40.0% | 23,100 | -22.0% | 0.00% | – |
Q3 2021 | $130,000 | +0.8% | 29,600 | 0.0% | 0.00% | – |
Q2 2021 | $129,000 | +4.9% | 29,600 | +10742.5% | 0.00% | – |
Q1 2021 | $123,000 | – | 273 | +162.5% | 0.00% | – |
Q4 2020 | $0 | – | 104 | -33.3% | 0.00% | – |
Q3 2020 | $0 | – | 156 | -82.6% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 896 | +1471.9% | 0.00% | – |
Q1 2020 | $8,000 | -55.6% | 57 | -38.0% | 0.00% | – |
Q4 2019 | $18,000 | -43.8% | 92 | +46.0% | 0.00% | – |
Q3 2019 | $32,000 | -87.4% | 63 | -82.3% | 0.00% | -100.0% |
Q2 2019 | $254,000 | +408.0% | 356 | +836.8% | 0.00% | – |
Q1 2019 | $50,000 | +127.3% | 38 | +35.7% | 0.00% | – |
Q4 2018 | $22,000 | -40.5% | 28 | -17.6% | 0.00% | – |
Q3 2018 | $37,000 | +42.3% | 34 | +70.0% | 0.00% | – |
Q2 2018 | $26,000 | +271.4% | 20 | -13.0% | 0.00% | – |
Q1 2018 | $7,000 | -53.3% | 23 | -43.9% | 0.00% | -100.0% |
Q4 2017 | $15,000 | +50.0% | 41 | +10.8% | 0.00% | – |
Q3 2017 | $10,000 | +900.0% | 37 | +1133.3% | 0.00% | – |
Q2 2017 | $1,000 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 53,700 | $196,000 | 0.00% |
SIMPLEX TRADING, LLC | 29,600 | $130,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |